Rare diseases
Investigational molecules
Locations
A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.
PolandA study to evaluate the efficacy and safety of obinutuzumab compared to prednisolone in adults with newly onset minimal change disease
AustriaA study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
FranceA study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma
GreeceA study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis
BulgariaA study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy
BulgariaA study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis
GermanyA study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication
BelgiumA study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer
GermanyA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
BelgiumA study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations
DenmarkA study comparing mifamurtide to sorafenib for treating high-risk osteosarcoma in children and young adults
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
